Berliner Institut für Gesundheitsforschung (BIH)
About Berliner Institut für Gesundheitsforschung (BIh)
The Berlin Institute of Health (BIH) is a scientific institution for translational and precision medicine. The BIH is dedicated to new approaches for better prognoses and novel therapies for progressive diseases and unmet medical needs in order to restore or maintain people's quality of life. Our focus is to understand the complex mechanisms and factors of severe disease progression and to define the individual risk for patients in order to improve the prediction of progressive diseases and to develop and apply novel therapies for personalized treatments. Our goal is to pave the way for benefit-oriented personalized healthcare through translational cutting-edge research and innovation. Charité - Universitätsmedizin Berlin and the Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) are founding institutions and independent members of the BIH. The BIH combines the strengths of Charité and MDC in a joint research area.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
- Industry : Healthcare
